Healthcare & Life Sciences
Ascidian Therapeutics
United Statesascidian-tx.com/
Ascidian Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Ascidian Therapeutics
Ascidian Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ascidian Therapeutics develops RNA exon editing therapeutics that replace mutated human exons to restore normal protein production, targeting genetically defined diseases without altering DNA.
Explore Ascidian Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.